1) HBV PreS1 peptides
HBV PreS1多肽
1.
Objective: To detect the immune reaction of HBV PreS1 peptides with different genotype and evaluate the potential influence for host immunity of the peptides as a new entry inhibitors for the treatment of acute and chronic hepatitis B virus infection.
目的：检测不同基因型的HBV PreS1多肽的免疫反应，评估其作为一种新的入胞抑制剂用于治疗急慢性HBV感染对机体免疫系统可能造成的影响。
2) HBV PreS1 peptide
HBV前S1肽
3) HBV PreS2 peptide
HBV前S2肽
4) Hepatitis B virus
HBV
1.
In vitro investigation on the influence of interferon-inducible mutant E645R on the inhibitory effect of MXA protein upon the replication of hepatitis B virus;
E645R变异MXA蛋白抗HBV复制体外研究
2.
Investigation on Hepatitis B Virus among Employees from Catering Enterprises and Public Places in Nanhai District of Foshan from 2002 to 2006;
2002～2006年佛山市南海区食品及公共场所从业人员HBV携带情况分析
3.
Objective To analyse the reasons for hepatitis B virus(HBV) reinfection following orthotopic liver transplantation and the experience of preventing HBV reinfection.
目的分析乙型肝炎病毒(HBV)相关性肝病肝移植术后HBV再感染的原因及防治经验。
5) Hepatitis B virus (HBV)
HBV
1.
Objective: To investigate the expression of p53 protein in hepatocellular carcinoma (HCC) and its relationship with clinical pathological feature and prognosis of HCC and alpha-fetopritein (AFP), hepatitis B virus (HBV) infection in HCC.
目的:探讨p53与肝细胞癌临床病理学特征和患者预后、AFP、HBV感染之间的关系。
2.
Objective To explore the effect of antisense RNA on hepatitis B virus (HBV) replication and antigen synthesis.
目的 了解反义乙型肝炎病毒 (HBV)基因转移、表达的抗HBV作用。
3.
In this study, we tried to construct a SNP and haplotype database of Chinese population in chromosome 21; compare the sequence between human and primates; look for genes associated with complex disease or environmental fact and analysis the hepatitis B virus (HBV) by polymorphisms.
在本论文中我们拟建立人类21号染色体中国人SNP数据目录和单倍型图谱，寻找人类与黑猩猩等灵长类动物的序列差异，并将SNP应用于复杂疾病（原发性高血压）致病基因的寻找，环境因子敏感基因（相同苯环境下更易引发苯中毒）的寻找和乙型肝炎（hepatitis B virus，HBV）病毒株的研究。
6) show colours with the action of enzyme
HBV DNA多态性
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条